72 related articles for article (PubMed ID: 27306534)
1. Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
Hsu CC; Chen CL; Wang CC; Lin CC; Yong CC; Wang SH; Liu YW; Lin TL; Lee WF; Lin YH; Chan YC; Wu YJ; Eng HL; Cheng YF
Transplantation; 2016 Sep; 100(9):1925-32. PubMed ID: 27306534
[TBL] [Abstract][Full Text] [Related]
2. The potential of
Jiang S; Gao X; Tian Y; Chen J; Wang Y; Jiang Y; He Y
Abdom Radiol (NY); 2024 May; 49(5):1444-1455. PubMed ID: 38265452
[TBL] [Abstract][Full Text] [Related]
3. Risk assessment in liver transplantation for hepatocellular carcinoma: long-term follow-up of a two-centre experience.
Wehrle CJ; Raj R; Maspero M; Satish S; Eghtesad B; Pita A; Kim J; Khalil M; Calderon E; Orabi D; Zervos B; Modaresi Esfeh J; Whitsett Linganna M; Diago-Uso T; Fujiki M; Quintini C; Kwon CD; Miller C; Pinna A; Aucejo F; Hashimoto K; Schlegel A
Int J Surg; 2024 May; 110(5):2818-2831. PubMed ID: 38241354
[TBL] [Abstract][Full Text] [Related]
4. Post-transplant inflammatory cytokine signature adds value for predicting tumor recurrence after liver transplantation for hepatocellular carcinoma.
Ng KT; Liu J; Yeung OW; Pang L; Shiu HC; Liu H; Yang XX; Chan AC; Wong TC; Lo CM; Man K
Hepatol Int; 2023 Dec; 17(6):1596-1609. PubMed ID: 37542605
[TBL] [Abstract][Full Text] [Related]
5. SUV max as Predictor of Metastatic Disease on 18 F-FDG PET-CT in Hepatocellular Carcinoma.
Ashfaq W; Rehman K; Shahid A; Younis MN
J Coll Physicians Surg Pak; 2024 Apr; 34(4):394-399. PubMed ID: 38576279
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of eligibility criteria in living donor liver transplantation for hepatocellular carcinoma by α-SMA-positive cancer-associated fibroblasts.
Takamura H; Nakanuma S; Hayashi H; Tajima H; Kakinoki K; Sakai S; Makino I; Nakagawara H; Miyashita T; Okamoto K; Nakamura K; Oyama K; Inokuchi M; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Ohnishi I; Kayahara M; Tani T; Arai K; Yamashita T; Yamashita T; Kitamura H; Ikeda H; Kaneko S; Nakanuma Y; Matsui O; Ohta T
Oncol Rep; 2013 Oct; 30(4):1561-74. PubMed ID: 23863893
[TBL] [Abstract][Full Text] [Related]
7. The predictive value of
Luo XY; Chang KW; Ye N; Gao CH; Zhu QB; Liu JP; Zhou X; Zheng SS; Yang Z
Front Med (Lausanne); 2024; 11():1380750. PubMed ID: 38799149
[TBL] [Abstract][Full Text] [Related]
8.
Hu XG; Shen XY; Nan JN; Kim IG; Yoon JK; Hong SY; Kim MN; Kim BW; Wang HJ
Ann Surg Treat Res; 2020 Jul; 99(1):8-17. PubMed ID: 32676477
[TBL] [Abstract][Full Text] [Related]
9. Small graft size and hepatocellular carcinoma outcomes in living donor liver transplantation: a retrospective multicentric cohort study.
Kim DG; Hwang S; Lee KW; Kim JM; You YK; Choi D; Ryu JH; Kim BW; Kim DS; Cho JY; Nah YW; Ju MK; Kim TS; Lee JG; Kim MS; Parente A; Kim KH; Schlegel A; Choi SJN; Joo DJ;
Int J Surg; 2024 May; ():. PubMed ID: 38701521
[TBL] [Abstract][Full Text] [Related]
10. Impact of donor characteristics on hepatocellular carcinoma recurrence after liver transplantation.
Akabane M; Bekki Y; Imaoka Y; Inaba Y; Esquivel CO; Melcher ML; Kwong A; Sasaki K
Br J Surg; 2024 Apr; 111(4):. PubMed ID: 38630794
[No Abstract] [Full Text] [Related]
11. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection.
Chan AWH; Zhong J; Berhane S; Toyoda H; Cucchetti A; Shi K; Tada T; Chong CCN; Xiang BD; Li LQ; Lai PBS; Mazzaferro V; García-Fiñana M; Kudo M; Kumada T; Roayaie S; Johnson PJ
J Hepatol; 2018 Dec; 69(6):1284-1293. PubMed ID: 30236834
[TBL] [Abstract][Full Text] [Related]
12. Emerging role of
Lee SM; Kim HS; Lee S; Lee JW
World J Gastroenterol; 2019 Mar; 25(11):1289-1306. PubMed ID: 30918424
[TBL] [Abstract][Full Text] [Related]
13. Composite criteria using clinical and FDG PET/CT factors for predicting recurrence of hepatocellular carcinoma after living donor liver transplantation.
Kang YK; Choi JY; Paeng JC; Kim YI; Kwon HW; Cheon GJ; Suh KS; Kwon CHD; Lee DS; Kang KW
Eur Radiol; 2019 Nov; 29(11):6009-6017. PubMed ID: 31115626
[TBL] [Abstract][Full Text] [Related]
14. FDG-PET predicted unfavorable tumor histology in living donor liver transplant recipients; a retrospective cohort study.
Ling LL; Hsu CC; Yong CC; Elsarawy AM; Chan YC; Wang CC; Li WF; Lin TL; Kuo FY; Cheng YF; Lin LM; Chen CL; Lin CC
Int J Surg; 2019 Sep; 69():124-131. PubMed ID: 31386913
[TBL] [Abstract][Full Text] [Related]
15. Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.
Takada Y; Kaido T; Shirabe K; Nagano H; Egawa H; Sugawara Y; Taketomi A; Takahara T; Wakabayashi G; Nakanishi C; Kawagishi N; Kenjo A; Gotoh M; Toyoki Y; Hakamada K; Ohtsuka M; Akamatsu N; Kokudo N; Takeda K; Endo I; Takamura H; Okajima H; Wada H; Kubo S; Kuramitsu K; Ku Y; Ishiyama K; Ohdan H; Ito E; Maehara Y; Honda M; Inomata Y; Furukawa H; Uemoto S; Yamaue H; Miyazaki M; Takada T;
J Hepatobiliary Pancreat Sci; 2017 Jan; 24(1):49-57. PubMed ID: 27806426
[TBL] [Abstract][Full Text] [Related]
16. Proton beam therapy for downstaging hepatocellular carcinoma with lobar portal vein tumor thrombosis to living donor liver transplantation.
Chen CL; Dungca LBP; Yong CC; Chen IC; Cheng YF; Cheng JY; Chen YY
Hepatobiliary Surg Nutr; 2023 Dec; 12(6):966-974. PubMed ID: 38115927
[No Abstract] [Full Text] [Related]
17. Predicting Outcome after Percutaneous Ablation for Early-Stage Hepatocellular Carcinoma Using Various Imaging Modalities.
Shimizu R; Ida Y; Kitano M
Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835800
[TBL] [Abstract][Full Text] [Related]
18. Predicting Overall Survival with Deep Learning from 18F-FDG PET-CT Images in Patients with Hepatocellular Carcinoma before Liver Transplantation.
Lai YC; Wu KC; Chang CJ; Chen YJ; Wang KP; Jeng LB; Kao CH
Diagnostics (Basel); 2023 Mar; 13(5):. PubMed ID: 36900125
[TBL] [Abstract][Full Text] [Related]
19. Tumor metabolism derived from
Hu S; Xie Y; Yang T; Yang Y; Zou Q; Jiao J; Zhang Y
Quant Imaging Med Surg; 2023 Jan; 13(1):309-319. PubMed ID: 36620154
[TBL] [Abstract][Full Text] [Related]
20. Utility of PET Scans in the Diagnosis and Management of Gastrointestinal Tumors.
Menon N; Mandelkern M
Dig Dis Sci; 2022 Oct; 67(10):4633-4653. PubMed ID: 35908126
[No Abstract] [Full Text] [Related]
[Next] [New Search]
